CUMYL-FUBINACA (SGT-149) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist, with an EC50 of 1.8nM for human CB1 receptors and 23.7nM for human CB2 receptors, giving it around 13x selectivity for CB1.[1][2][3][4] It has been sold online as a designer drug.[5]
Legal status | |
---|---|
Legal status | |
Identifiers | |
| |
PubChem CID |
|
UNII |
|
Chemical and physical data | |
Formula | C24H22FN3O |
Molar mass | 387.458 g·mol−1 |
3D model (JSmol) |
|
| |
|